Over 12 months, Immunome Inc. saw more selling than buying from its insiders — purchases of about $2.3 million against sales of $27.5 million.
SIEGALL CLAY B (CEO) made the biggest buy, worth around $1,000,000. C-suite participation is part of the picture here.
On the institutional side, 202 funds reported holding IMNM at the end of Q2 2026, and more funds bought than sold. Quarter by quarter: 4 quarters in a row of net selling by insiders. Insiders bought in 5 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Higgins Jack | Executive Officer | Sell | 13,200 | $25.32 | $334K | SEC |
| Aug 12, 2026 | Barchas Isaac | Director | Sell | 11,048 | $27.25 | $301K | SEC |
| Aug 12, 2026 | Barchas Isaac | Director | Sell | 62,291 | $26.23 | $1.6M | SEC |
| Aug 12, 2026 | Barchas Isaac | Director | Sell | 10,125 | $26.07 | $264K | SEC |
| Aug 10, 2026 | Barchas Isaac | Director | Sell | 20,840 | $26.06 | $543K | SEC |
| Aug 10, 2026 | Barchas Isaac | Director | Sell | 15,248 | $26.06 | $397K | SEC |
| Aug 6, 2026 | Horn Kinney | Executive Officer | Sell | 90,616 | $25.09 | $2.3M | SEC |
| Jul 9, 2026 | Horn Kinney | Executive Officer | Sell | 1,092 | $25.00 | $27K | SEC |
| Jul 7, 2026 | Barchas Isaac | Director | Sell | 16,906 | $24.20 | $409K | SEC |
| Jul 7, 2026 | Barchas Isaac | Director | Sell | 83,094 | $24.11 | $2.0M | SEC |
| Jul 7, 2026 | Lechleider Robert | Executive Officer | Sell | 16,072 | $23.44 | $377K | SEC |
| Jul 7, 2026 | Lechleider Robert | Executive Officer | Sell | 16,214 | $22.76 | $369K | SEC |
| Jul 7, 2026 | Lechleider Robert | Executive Officer | Sell | 22,714 | $21.95 | $499K | SEC |
| Jul 2, 2026 | Barchas Isaac | Director | Sell | 75,665 | $22.35 | $1.7M | SEC |
| Jul 2, 2026 | Barchas Isaac | Director | Sell | 24,335 | $23.33 | $568K | SEC |
In the last 12 months Immunome Inc. insiders made open-market purchases worth about $2.3 million and sales worth about $27.5 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in IMNM was filed on 2026-09-15.
202 investment managers reported holding IMNM in SEC Form 13F filings for Q2 2026.
No congressional trades in IMNM were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).